26.90
1.42%
0.3766
After Hours:
26.96
0.0616
+0.23%
Tema Oncology Etf Stock (CANC) Forecast
The Tema Oncology Etf (CANC) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $30.86, representing a +14.74% increase from the current price of $26.90. The highest analyst price target is $32.22, and the lowest is $29.51.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CANC Price Target
Average 33.10
(+23.04% Upside)
Is Tema Oncology Etf (CANC) A Buy Now?
Oscillators
Name | Value | Action |
---|---|---|
RSI(14) | 42.07 | Neutral |
STOCH(9,6) | 14.38 | Buy |
STOCHRSI(14) | 46.11 | Neutral |
MACD(12,26) | -0.469 | Sell |
ADX(14) | 23.01 | Neutral |
William %R | -67.02 | Neutral |
CCI(14) | -41.92 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
Period | Simple | Exponential |
---|---|---|
MA10 |
27.01
Sell
|
26.92
Sell
|
MA20 |
27.56
Sell
|
27.33
Sell
|
MA50 |
28.04
Sell
|
27.86
Sell
|
MA100 |
28.46
Sell
|
27.97
Sell
|
MA200 |
27.85
Sell
|
27.37
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CANC could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 11 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on CANC, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 42.07 indicates that CANC is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 14.38 indicates that CANC is oversold. This indicates that CANC price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 46.11 indicates that CANC is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.01 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -41.92 indicates that CANC is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term CANC price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Tema Oncology Etf financial reports and earnings history, Tema Oncology Etf (CANC) stock could reach $59.91 by 2030, $124.09 by 2040 and $172.15 by 2050. See the projected annual prices until 2050 of the Tema Oncology Etf stock below:
- Tema Oncology Etf (CANC) is expected to reach an average price of $91.27 in 2035, with a high prediction of $91.55 and a low estimate of $89.49. This indicates an $239.32% rise from the last recorded price of $26.90.
- Tema Oncology Etf (CANC) stock is projected to chart a bullish course in 2040, with an average price target of $123.72, representing an $359.97% surge from its current level. The forecast ranges from a conservative $122.98 to a sky-high $124.09.
- Our analysts predict Tema Oncology Etf (CANC) to jump 415.24% by 2045, soaring from $137.77 to an average price of $138.59, potentially reaching $156.31. While $137.77 is the low estimate, the potential upside is significant.
- Tema Oncology Etf (CANC) stock is expected to climb by 2050, reaching an average of $172.15, a $540.01% jump from its current level. However, a wide range of estimates exists, with high and low targets of $172.15 and $167.73, respectively, highlighting the market's uncertainty.
Tema Oncology Etf Stock (CANC) Year by Year Forecast
Tema Oncology Etf Stock (CANC) Price Forecast for 2024
Our forecast for CANC stock price in 2024 now indicates an average price target of $29.15 with a high forecast of $33.28 and a low forecast of $25.03. The average prediction reflects an increase of +8.38% from the last recorded price of $26.90.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
December, 2024 | $30.21 | $29.51 | $32.22 | +12.30% |
Tema Oncology Etf Stock (CANC) Price Forecast for 2025
Tema Oncology Etf Stock (CANC) is expected to reach an average price of $33.69 in 2025, with a high prediction of $38.58 and a low estimate of $28.80. This indicates an +25.24% rise from the last recorded price of $26.90.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2025 | $29.69 | $29.55 | $31.58 | +10.36% |
February, 2025 | $29.71 | $28.80 | $30.95 | +10.45% |
March, 2025 | $32.26 | $29.63 | $32.26 | +19.92% |
April, 2025 | $34.15 | $31.93 | $34.62 | +26.94% |
May, 2025 | $34.22 | $33.46 | $34.89 | +27.22% |
June, 2025 | $36.19 | $34.31 | $36.25 | +34.55% |
July, 2025 | $35.84 | $35.22 | $37.40 | +33.26% |
August, 2025 | $33.77 | $33.76 | $36.53 | +25.55% |
September, 2025 | $34.32 | $33.61 | $35.88 | +27.59% |
October, 2025 | $34.63 | $32.57 | $34.74 | +28.76% |
November, 2025 | $35.64 | $33.16 | $35.64 | +32.49% |
December, 2025 | $38.25 | $35.83 | $38.58 | +42.22% |
Tema Oncology Etf Stock (CANC) Price Forecast for 2026
The predicted value for Tema Oncology Etf (CANC) in 2026 is set at an average of $40.98. Estimates vary from a peak of $45.63 to a trough of $36.34, indicating an +52.37% surge from the present price of $26.90.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2026 | $38.28 | $37.46 | $38.75 | +42.30% |
February, 2026 | $40.14 | $38.26 | $40.34 | +49.21% |
March, 2026 | $40.61 | $39.98 | $41.52 | +50.99% |
April, 2026 | $38.95 | $38.95 | $40.73 | +44.82% |
May, 2026 | $39.10 | $38.01 | $40.18 | +45.35% |
June, 2026 | $36.34 | $36.34 | $38.16 | +35.09% |
July, 2026 | $38.74 | $36.62 | $38.74 | +44.03% |
August, 2026 | $41.12 | $38.40 | $41.48 | +52.86% |
September, 2026 | $41.83 | $40.68 | $42.73 | +55.52% |
October, 2026 | $43.42 | $41.95 | $43.43 | +61.44% |
November, 2026 | $45.23 | $42.70 | $45.63 | +68.15% |
December, 2026 | $43.90 | $43.59 | $44.93 | +63.21% |
Tema Oncology Etf Stock (CANC) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Tema Oncology Etf (CANC) is $44.93, with a high forecast of $49.75 and a low forecast of $40.11. This indicates an +67.03% increase from the last price of $26.90.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2027 | $43.71 | $42.26 | $44.26 | +62.49% |
February, 2027 | $40.95 | $40.81 | $44.48 | +52.22% |
March, 2027 | $42.21 | $40.11 | $42.41 | +56.92% |
April, 2027 | $44.08 | $42.12 | $44.30 | +63.89% |
May, 2027 | $46.05 | $44.06 | $46.48 | +71.21% |
June, 2027 | $46.70 | $45.47 | $47.00 | +73.62% |
July, 2027 | $48.80 | $46.79 | $49.75 | +81.43% |
August, 2027 | $48.40 | $47.77 | $49.36 | +79.93% |
September, 2027 | $47.28 | $46.52 | $49.13 | +75.77% |
October, 2027 | $45.18 | $44.77 | $48.78 | +67.95% |
November, 2027 | $46.04 | $43.88 | $46.15 | +71.17% |
December, 2027 | $47.80 | $44.62 | $47.80 | +77.71% |
Tema Oncology Etf Stock (CANC) Price Forecast for 2028
In 2028, Tema Oncology Etf (CANC) is projected to reach an average price of $52.76, with a high projection of $57.99 and a low estimate of $47.54. This indicates an +96.15% rise from the last price of $26.90.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2028 | $50.11 | $47.54 | $50.43 | +86.30% |
February, 2028 | $50.33 | $49.47 | $50.70 | +87.12% |
March, 2028 | $52.60 | $50.36 | $52.65 | +95.54% |
April, 2028 | $52.15 | $52.12 | $53.87 | +93.87% |
May, 2028 | $50.78 | $50.77 | $53.33 | +88.77% |
June, 2028 | $49.20 | $48.49 | $53.09 | +82.91% |
July, 2028 | $48.51 | $47.65 | $49.42 | +80.36% |
August, 2028 | $51.12 | $48.44 | $51.12 | +90.03% |
September, 2028 | $53.51 | $51.44 | $53.51 | +98.94% |
October, 2028 | $53.84 | $53.47 | $54.69 | +100.16% |
November, 2028 | $56.48 | $54.00 | $56.68 | +109.96% |
December, 2028 | $57.22 | $56.38 | $57.99 | +112.73% |
Tema Oncology Etf Stock (CANC) Price Forecast for 2029
The 2029 price forecast for Tema Oncology Etf Stock (CANC) is $56.76 on average, with a high prediction of $62.11 and a low estimate of $51.42. This represents an +111.02% increase from the previous price of $26.90.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2029 | $55.89 | $55.89 | $57.53 | +107.79% |
February, 2029 | $56.20 | $55.02 | $57.39 | +108.94% |
March, 2029 | $51.42 | $51.42 | $53.18 | +91.15% |
April, 2029 | $53.72 | $51.76 | $53.87 | +99.70% |
May, 2029 | $56.79 | $53.67 | $57.16 | +111.14% |
June, 2029 | $58.39 | $56.43 | $58.67 | +117.09% |
July, 2029 | $58.86 | $57.47 | $59.14 | +118.81% |
August, 2029 | $61.77 | $59.04 | $62.11 | +129.64% |
September, 2029 | $61.73 | $60.33 | $61.73 | +129.49% |
October, 2029 | $60.84 | $59.27 | $61.74 | +126.20% |
November, 2029 | $55.96 | $55.83 | $61.69 | +108.04% |
December, 2029 | $56.45 | $55.19 | $57.69 | +109.85% |
Tema Oncology Etf Stock (CANC) Price Forecast for 2030
Tema Oncology Etf Stock (CANC) is expected to reach an average price of $62.71 in 2030, with a high forecast of $68.93 and a low forecast of $56.49. This signifies an +133.13% surge from the last price of $26.90.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2030 | $59.69 | $56.49 | $59.91 | +121.92% |
February, 2030 | $61.93 | $59.73 | $62.33 | +130.23% |
March, 2030 | $62.47 | $61.47 | $63.14 | +132.24% |
April, 2030 | $64.90 | $62.67 | $64.96 | +141.29% |
May, 2030 | $65.14 | $64.51 | $66.23 | +142.16% |
June, 2030 | $63.53 | $63.52 | $65.96 | +136.19% |
July, 2030 | $60.12 | $59.65 | $65.99 | +123.52% |
August, 2030 | $61.25 | $58.96 | $61.36 | +127.73% |
September, 2030 | $62.72 | $59.90 | $62.72 | +133.19% |
October, 2030 | $65.92 | $63.15 | $66.24 | +145.07% |
November, 2030 | $66.41 | $65.48 | $66.65 | +146.88% |
December, 2030 | $68.73 | $66.50 | $68.93 | +155.52% |
Cap:
|
Volume (24h):